Child's Nervous System

, Volume 30, Issue 1, pp 47–64 | Cite as

Familial syndromes associated with intracranial tumours: a review

  • Adrianna M. Ranger
  • Yatri K. Patel
  • Navjot Chaudhary
  • Ram V. Anantha
Review Paper



Most cancers of the central nervous system (CNS) occur sporadically in the absence of any known underlying familial disorder or multi-systemic syndrome. Several syndromes are associated with CNS malignancies, however, and their recognition has significant implications for patient management and prognosis. Patients with syndrome-associated CNS malignancies often have multiple tumours (either confined to one region or distributed throughout the body), with similar or different histology.


This review examines syndromes that are strongly associated with CNS cancers: the phakomatosis syndromes, familial syndromes such as Li–Fraumeni and familial polyposis syndromes and dyschondroplasia.


Central nervous system malignancies Familial syndromes Phakomatosis syndromes Dyschondroplasia 


  1. 1.
    Pan E, Prados MD (2003) Familial Tumors Syndromes of the Central Nervous system. BC Decker, HamiltonGoogle Scholar
  2. 2.
    Anonymous (1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578Google Scholar
  3. 3.
    Crino PB, Henske EP (1999) New developments in the neurobiology of the tuberous sclerosis complex. Neurology 53:1384–1390PubMedGoogle Scholar
  4. 4.
    Koeller KK, Rosenblum RS, Morrison AL (2000) Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics 20:1721–1749PubMedGoogle Scholar
  5. 5.
    Esiri M, Squier W, Perl D (2006) Oppenheimer’s diagnostic neuropathology: a practical manual. CRC Press, Boca RatonGoogle Scholar
  6. 6.
    Hottinger AF, Khakoo Y (2009) Neurooncology of familial cancer syndromes. J Child Neurol 24:1526–1535PubMedGoogle Scholar
  7. 7.
    Bondy M, Wiencke J, Wrensch M, Kyritsis AP (1994) Genetics of primary brain tumors: a review. J Neurooncol 18:69–81PubMedGoogle Scholar
  8. 8.
    Korf BR (2005) The phakomatoses. Clin Dermatol 23:78–84PubMedGoogle Scholar
  9. 9.
    Van der Hoeve J (1920) Eye symptoms in tuberous sclerosis of the brain. Trans Ophthalmol Soc UK 40:329–334Google Scholar
  10. 10.
    Alaraj AM, Valyi-Nagy T, Roitberg B (2007) Double phakomatosis; neurofibromatosis type-1 and tuberous sclerosis. Acta Neurochir (Wien) 149:505–509, discussion 509Google Scholar
  11. 11.
    Ferner RE (2007) Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 6:340–351PubMedGoogle Scholar
  12. 12.
    Rieley MB, Stevenson DA, Viskochil DH, Tinkle BT, Martin LJ, Schorry EK (2011) Variable expression of neurofibromatosis 1 in monozygotic twins. Am J Med Genet A 155A:478–485PubMedGoogle Scholar
  13. 13.
    Zoller ME, Rembeck B, Oden A, Samuelsson M, Angervall L (1997) Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 79:2125–2131PubMedGoogle Scholar
  14. 14.
    Lu-Emerson C, Plotkin SR (2009) The Neurofibromatoses. Part 1: NF1. Rev Neurol Dis 6:E47–E53PubMedGoogle Scholar
  15. 15.
    Lu-Emerson C, Plotkin SR (2009) The neurofibromatoses. Part 2: NF2 and schwannomatosis. Rev Neurol Dis 6:E81–E86PubMedGoogle Scholar
  16. 16.
    Pearce JM (2003) Neurofibromatosis. J Neurol Neurosurg Psychiatry 74:384PubMedGoogle Scholar
  17. 17.
    Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81–88PubMedGoogle Scholar
  18. 18.
    Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A:327–332PubMedGoogle Scholar
  19. 19.
    Legendre CM, Charpentier-Cote C, Drouin R, Bouffard C (2011) Neurofibromatosis type 1 and the "elephant man’s" disease: the confusion persists: an ethnographic study. PloS One 6:e16409PubMedCentralPubMedGoogle Scholar
  20. 20.
    Ferner RE (2010) The neurofibromatoses. Pract Neurol 10:82–93PubMedGoogle Scholar
  21. 21.
    Hottinger AF, Khakoo Y (2009) Neuro-oncology of neurofibromatosis type 1. Curr Treat Options Neurol 11:306–314PubMedGoogle Scholar
  22. 22.
    Uhlmann EJ, Plotkin SR (2012) Neurofibromatoses. Adv Exp Med Biol 724:266–277PubMedGoogle Scholar
  23. 23.
    DeBella K, Szudek J, Friedman JM (2000) Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 105:608–614PubMedGoogle Scholar
  24. 24.
    Sezer E, Senayli A, Sezer T, Bicakci U (2006) Segmental neurofibromatosis: report of two cases. J Dermatol 33:635–638PubMedGoogle Scholar
  25. 25.
    Mansur AT, Goktay F, Akkaya AD, Gunes P (2011) Segmental neurofibromatosis: report of 3 cases. Cutis 87:45–50PubMedGoogle Scholar
  26. 26.
    Morais P, Ferreira O, Bettencourt H, Azevedo F (2010) Segmental neurofibromatosis: a rare variant of a common genodermatosis. Acta Dermatovenerol Alp Panonica Adriat 19:27–29PubMedGoogle Scholar
  27. 27.
    Arfan ul B, Simeen ber R (2003) Segmental neurofibromatosis [NF type-v]. J Coll Physician Surg Pak 13:717–718Google Scholar
  28. 28.
    Dang JD, Cohen PR (2010) Segmental neurofibromatosis and malignancy. Skinmed 8:156–159PubMedGoogle Scholar
  29. 29.
    Hersh JH (2008) Health supervision for children with neurofibromatosis. Pediatrics 121:633–642PubMedGoogle Scholar
  30. 30.
    American Academy of Pediatrics Committee on Genetics (1995) Health supervision for children with neurofibromatosis. Pediatrics 96:368–372Google Scholar
  31. 31.
    Huson SM, Harper PS, Compston DA (1988) Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 111(Pt 6):1355–1381PubMedGoogle Scholar
  32. 32.
    Lopes Ferraz Filho JR, Munis MP, Soares Souza A, Sanches RA, Goloni-Bertollo EM, Pavarino-Bertelli EC (2008) Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1. Pediatr Radiol 38:305–310PubMedGoogle Scholar
  33. 33.
    North KN, Riccardi V, Samango-Sprouse C, Ferner R, Moore B, Legius E, Ratner N, Denckla MB (1997) Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology 48:1121–1127PubMedGoogle Scholar
  34. 34.
    Arun D, Gutmann DH (2004) Recent advances in neurofibromatosis type 1. Curr Opin Neurol 17:101–105PubMedGoogle Scholar
  35. 35.
    North K, Joy P, Yuille D, Cocks N, Hutchins P (1995) Cognitive function and academic performance in children with neurofibromatosis type 1. Dev Med Child Neurol 37:427–436PubMedGoogle Scholar
  36. 36.
    North K, Joy P, Yuille D, Cocks N, Mobbs E, Hutchins P, McHugh K, de Silva M (1994) Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology 44:878–883PubMedGoogle Scholar
  37. 37.
    Denckla MB, Hofman K, Mazzocco MM, Melhem E, Reiss AL, Bryan RN, Harris EL, Lee J, Cox CS, Schuerholz LJ (1996) Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet 67:98–102PubMedGoogle Scholar
  38. 38.
    Hyman SL, Gill DS, Shores EA, Steinberg A, Joy P, Gibikote SV, North KN (2003) Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1. Neurology 60:1139–1145PubMedGoogle Scholar
  39. 39.
    Joy P, Roberts C, North K, de Silva M (1995) Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol 37:906–914PubMedGoogle Scholar
  40. 40.
    Dodge HW Jr, Love JG, Craig WM, Dockerty MB, Kearns TP, Holman CB, Hayles AB (1958) Gliomas of the optic nerves. AMA Arch Neurol Psychiatry 79:607–621PubMedGoogle Scholar
  41. 41.
    Massimi L, Tufo T, Di Rocco C (2007) Management of optic-hypothalamic gliomas in children: still a challenging problem. Expert Rev Anticancer Ther 7:1591–1610PubMedGoogle Scholar
  42. 42.
    Giuffre R, Bardelli AM, Taverniti L, Barberi L (1982) Anterior optic pathways gliomas. The dilemma of treatment. J Neurosurg Sci 26:61–72PubMedGoogle Scholar
  43. 43.
    Valdueza JM, Cristante L, Freitag J, Hagel C, Herrmann HD (1995) Malignant chiasmal glioma: a rare cause of rapid visual loss. Neurosurg Rev 18:273–275PubMedGoogle Scholar
  44. 44.
    Poussaint TY, Barnes PD, Nichols K, Anthony DC, Cohen L, Tarbell NJ, Goumnerova L (1997) Diencephalic syndrome: clinical features and imaging findings. AJNR Am J Neuroradiol 18:1499–1505PubMedGoogle Scholar
  45. 45.
    Oh KS, Hung J, Robertson PL, Garton HJ, Muraszko KM, Sandler HM, Hamstra DA (2011) Outcomes of multidisciplinary management in pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys 81:e481–e488PubMedGoogle Scholar
  46. 46.
    Boman KK, Hoven E, Anclair M, Lannering B, Gustafsson G (2009) Health and persistent functional late effects in adult survivors of childhood CNS tumours: a population-based cohort study. Eur J Cancer 45:2552–2561PubMedGoogle Scholar
  47. 47.
    Ellenberg L, Liu Q, Gioia G, Yasui Y, Packer RJ, Mertens A, Donaldson SS, Stovall M, Kadan-Lottick N, Armstrong G, Robison LL, Zeltzer LK (2009) Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the Childhood Cancer Survivor Study. Neuropsychology 23:705–717PubMedCentralPubMedGoogle Scholar
  48. 48.
    Leonard JR, Perry A, Rubin JB, King AA, Chicoine MR, Gutmann DH (2006) The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1. Neurology 67:1509–1512PubMedGoogle Scholar
  49. 49.
    Woodruff JM (1999) Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet 89:23–30PubMedGoogle Scholar
  50. 50.
    Khosrotehrani K, Bastuji-Garin S, Riccardi VM, Birch P, Friedman JM, Wolkenstein P (2005) Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients. Am J Med Genet A 132A:49–53PubMedGoogle Scholar
  51. 51.
    Canavese F, Krajbich JI (2011) Resection of plexiform neurofibromas in children with neurofibromatosis type 1. J Pediatr Orthop 31:303–311PubMedGoogle Scholar
  52. 52.
    Levi AD, Ross AL, Cuartas E, Qadir R, Temple HT (2010) The surgical management of symptomatic peripheral nerve sheath tumors. Neurosurgery 66:833–840PubMedGoogle Scholar
  53. 53.
    Khong PL, Goh WH, Wong VC, Fung CW, Ooi GC (2003) MR imaging of spinal tumors in children with neurofibromatosis 1. AJR Am J Roentgenol 180:413–417PubMedGoogle Scholar
  54. 54.
    Sarica FB, Cekinmez M, Tufan K, Erdogan B, Sen O, Altinors MN (2008) A rare case of massive NF1 with invasion of entire spinal axis by neurofibromas: case report. Turk Neurosurg 18:99–106PubMedGoogle Scholar
  55. 55.
    Brown RM, Klesse LJ, Le LQ (2010) Cutaneous features predict paraspinal neurofibromas in neurofibromatosis type 1. J Invest Dermatol 130:2167–2169PubMedGoogle Scholar
  56. 56.
    Cherqui A, Kim DH, Kim SH, Park HK, Kline DG (2007) Surgical approaches to paraspinal nerve sheath tumors. Neurosurg Focus 22:E9PubMedGoogle Scholar
  57. 57.
    Baujat B, Krastinova-Lolov D, Blumen M, Baglin AC, Coquille F, Chabolle F (2006) Radiofrequency in the treatment of craniofacial plexiform neurofibromatosis: a pilot study. Plast Reconstr Surg 117:1261–1268PubMedGoogle Scholar
  58. 58.
    Greig AV, Kirkpatrick NA, Joshi N, Kelly M, Waterhouse N (2009) Giant hemifacial plexiform neurofibroma arising from trigeminal ganglion. J Craniofac Surg 20:833–836PubMedGoogle Scholar
  59. 59.
    Jackson IT (2001) Management of craniofacial neurofibromatosis. Facial Plast Surg Clin North Am 9:59–75, viiiPubMedGoogle Scholar
  60. 60.
    Jacquemin C, Bosley TM, Svedberg H (2003) Orbit deformities in craniofacial neurofibromatosis type 1. AJNR Am J Neuroradiol 24:1678–1682PubMedGoogle Scholar
  61. 61.
    Park BY, Hong JP, Lee WJ (2002) Netting operation to control neurofibroma of the face. Plast Reconstr Surg 109:1228–1236, discussion 1237PubMedGoogle Scholar
  62. 62.
    Visrutaratna P, Oranratanachai K, Singhavejsakul J (2004) Clinics in diagnostic imaging (96). Plexiform neurofibromatosis. Singapore Med J 45:188–192PubMedGoogle Scholar
  63. 63.
    Lantieri L, Meningaud JP, Grimbert P, Bellivier F, Lefaucheur JP, Ortonne N, Benjoar MD, Lang P, Wolkenstein P (2008) Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study. Lancet 372:639–645PubMedGoogle Scholar
  64. 64.
    Cheng L, Scheithauer BW, Leibovich BC, Ramnani DM, Cheville JC, Bostwick DG (1999) Neurofibroma of the urinary bladder. Cancer 86:505–513PubMedGoogle Scholar
  65. 65.
    Hahn JS, Chung JB, Han SH, Lee SW, Noh SH, Lee JT, Chun SI, Kim GH (1992) Intestinal neurofibromatosis in von Recklinghausen’s disease: presenting as chronic anemia due to recurrent intestinal hemorrhage. Korean J Intern Med 7:137–142PubMedGoogle Scholar
  66. 66.
    Kaefer M, Adams MC, Rink RC, Keating MA (1997) Principles in management of complex pediatric genitourinary plexiform neurofibroma. Urology 49:936–940PubMedGoogle Scholar
  67. 67.
    Bance M, Ramsden RT (1999) Management of neurofibromatosis type 2. Ear Nose Throat J 78(91–94):96Google Scholar
  68. 68.
    Baser ME, Dg RE, Gutmann DH (2003) Neurofibromatosis 2. Curr Opin Neurol 16:27–33PubMedGoogle Scholar
  69. 69.
    Evans DG (1999) Neurofibromatosis type 2: genetic and clinical features. Ear Nose Throat J 78:97–100PubMedGoogle Scholar
  70. 70.
    Fontaine B, Hanson MP, VonSattel JP, Martuza RL, Gusella JF (1991) Loss of chromosome 22 alleles in human sporadic spinal schwannomas. Ann Neurol 29:183–186PubMedGoogle Scholar
  71. 71.
    Fontaine B, Sanson M, Delattre O, Menon AG, Rouleau GA, Seizinger BR, Jewell AF, Hanson MP, Aurias A, Martuza RL et al (1991) Parental origin of chromosome 22 loss in sporadic and NF2 neuromas. Genomics 10:280–283PubMedGoogle Scholar
  72. 72.
    Jacoby LB, MacCollin M, Parry DM, Kluwe L, Lynch J, Jones D, Gusella JF (1999) Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis. Neurogenetics 2:101–108PubMedGoogle Scholar
  73. 73.
    Evans DG, Ramsden RT, Gokhale C, Bowers N, Huson SM, Wallace A (2007) Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma? Clin Genet 71:354–358PubMedGoogle Scholar
  74. 74.
    Hager CM, Cohen PR, Tschen JA (1997) Segmental neurofibromatosis: case reports and review. J Am Acad Dermatol 37:864–869PubMedGoogle Scholar
  75. 75.
    Patel J, Vasan R, van Loveren H, Downes K, Agazzi S (2013) The changing face of acoustic neuroma management in the USA: analysis of the 1998 and 2008 patient surveys from the acoustic neuroma association. Br J Neurosurg (2013)Google Scholar
  76. 76.
    Youssef TF, Matter A, Ahmed MR (2013) Surgical management of vestibular schwannoma: attempted preservation of hearing and facial function. J Laryngol Otol 127:473–478PubMedGoogle Scholar
  77. 77.
    Somers T, Van Havenbergh T (2012) Multidisciplinary management of vestibular schwannomas: state of the art. B-Ent 8:235–240PubMedGoogle Scholar
  78. 78.
    Szudek J, Briggs R, Leung R (2012) Surgery for neurofibromatosis 2. Curr Opin Otolaryngol Head and Neck Surg 20:347–352Google Scholar
  79. 79.
    Hoa M, Slattery WH 3rd (2012) Neurofibromatosis 2. Otolaryngol Clin N Am 45:315–332, viiiGoogle Scholar
  80. 80.
    Tysome JR, Macfarlane R, Durie-Gair J, Donnelly N, Mannion R, Knight R, Harris F, Vanat ZH, Tam YC, Burton K, Hensiek A, Raymond FL, Moffat DA, Axon PR (2012) Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2. Otol Neurotol: Off Publ Am Otological Soc, Am Neurotol Soc Eur Acad Otol Neurotol 33:466–472Google Scholar
  81. 81.
    Blakeley J (2012) Development of drug treatments for neurofibromatosis type 2-associated vestibular schwannoma. Curr Opin Otolaryngol Head and Neck Surg 20:372–379Google Scholar
  82. 82.
    Monteiro TA, Goffi-Gomez MV, Tsuji RK, Gomes MQ, Brito Neto RV, Bento RF (2012) Neurofibromatosis 2: hearing restoration options. Braz J Otorhinolaryngol 78:128–134PubMedGoogle Scholar
  83. 83.
    Kondziolka D, Mousavi SH, Kano H, Flickinger JC, Lunsford LD (2012) The newly diagnosed vestibular schwannoma: radiosurgery, resection, or observation? Neurosurg Focus 33:E8PubMedGoogle Scholar
  84. 84.
    Sasaki T, Shono T, Hashiguchi K, Yoshida F, Suzuki SO (2009) Histological considerations of the cleavage plane for preservation of facial and cochlear nerve functions in vestibular schwannoma surgery. J Neurosurg 110:648–655PubMedGoogle Scholar
  85. 85.
    Williams BJ, Xu Z, Salvetti DJ, McNeill IT, Larner J, Sheehan JP (2013) Gamma Knife surgery for large vestibular schwannomas: a single-center retrospective case-matched comparison assessing the effect of lesion size. J Neurosurg 119:463–471PubMedGoogle Scholar
  86. 86.
    Zeiler FA, Bigder M, Kaufmann A, McDonald PJ, Fewer D, Butler J, Schroeder G, West M (2013) Gamma knife radiosurgery for large vestibular schwannomas: a Canadian experience. Can J Neurol Sci J Can Sci Neurol 40:342–347Google Scholar
  87. 87.
    Caroli E, Russillo M, Ferrante L (2006) Intracranial meningiomas in children: report of 27 new cases and critical analysis of 440 cases reported in the literature. J Child Neurol 21:31–36PubMedGoogle Scholar
  88. 88.
    Ferrante L, Acqui M, Artico M, Mastronardi L, Rocchi G, Fortuna A (1989) Cerebral meningiomas in children. Child’s Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 5:83–86Google Scholar
  89. 89.
    Deb P, Gupta A, Sharma MC, Gaikwad S, Singh VP, Sarkar C (2006) Meningioangiomatosis with meningioma: an uncommon association of a rare entity–report of a case and review of the literature. Child’s Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 22:78–83Google Scholar
  90. 90.
    Omeis I, Hillard VH, Braun A, Benzil DL, Murali R, Harter DH (2006) Meningioangiomatosis associated with neurofibromatosis: report of 2 cases in a single family and review of the literature. Surg Neurol 65:595–603PubMedGoogle Scholar
  91. 91.
    Jallo GI, Kothbauer K, Mehta V, Abbott R, Epstein F (2005) Meningioangiomatosis without neurofibromatosis: a clinical analysis. J Neurosurg 103:319–324PubMedGoogle Scholar
  92. 92.
    Wixom C, Chadwick AE, Krous HF (2005) Sudden, unexpected death associated with meningioangiomatosis: case report. Pediatr Dev Pathol 8:240–244PubMedGoogle Scholar
  93. 93.
    Fisher LM, Doherty JK, Lev MH, Slattery WH 3rd (2007) Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2. Otol Neurotol Off Publ Am Otological Soc, Am Neurotol Soc European Acad Otol Neurotol 28:1083–1090Google Scholar
  94. 94.
    Hanada M, Tanaka T, Kanayama S, Takami M, Kimura M (1982) Malignant transformation of intrathoracic ancient neurilemoma in a patient without von Recklinghausen’s disease. Acta Pathol Jpn 32:527–536PubMedGoogle Scholar
  95. 95.
    Zhang H, Cai C, Wang S, Liu H, Ye Y, Chen X (2007) Extracranial head and neck schwannomas: a clinical analysis of 33 patients. Laryngoscope 117:278–281PubMedGoogle Scholar
  96. 96.
    Jee WH, Oh SN, McCauley T, Ryu KN, Suh JS, Lee JH, Park JM, Chun KA, Sung MS, Kim K, Lee YS, Kang YK, Ok IY, Kim JM (2004) Extraaxial neurofibromas versus neurilemmomas: discrimination with MRI. AJR Am J Roentgenol 183:629–633PubMedGoogle Scholar
  97. 97.
    Hong CH, Darling TN, Lee CH (2009) Prevalence of tuberous sclerosis complex in Taiwan: a national population-based study. Neuroepidemiology 33:335–341PubMedGoogle Scholar
  98. 98.
    Morrison PJ (2009) Tuberous sclerosis: epidemiology, genetics and progress towards treatment. Neuroepidemiology 33:342–343PubMedGoogle Scholar
  99. 99.
    Osborne JP, Fryer A, Webb D (1991) Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 615:125–127PubMedGoogle Scholar
  100. 100.
    Harrison JE, Bolton PF (1997) Annotation: tuberous sclerosis. J Child Psychol Psychiatry 38:603–614PubMedGoogle Scholar
  101. 101.
    Ridler K, Suckling J, Higgins NJ, de Vries PJ, Stephenson CM, Bolton PF, Bullmore ET (2007) Neuroanatomical correlates of memory deficits in tuberous sclerosis complex. Cereb Cortex 17:261–271PubMedGoogle Scholar
  102. 102.
    Orlova KA, Crino PB (2010) The tuberous sclerosis complex. Ann N Y Acad Sci 1184:87–105PubMedCentralPubMedGoogle Scholar
  103. 103.
    Grajkowska W, Kotulska K, Jurkiewicz E, Matyja E (2010) Brain lesions in tuberous sclerosis complex. Review. Folia Neuropathol 48:139–149PubMedGoogle Scholar
  104. 104.
    Hou JW, Wang PJ, Wang TR (1994) Tuberous sclerosis in children. Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal] Zhonghua Minguo xiao er ke yi xue hui 35:102–107Google Scholar
  105. 105.
    Curatolo P, Maria BL (2013) Tuberous sclerosis. Handb Clin Neurol 111:323–331PubMedGoogle Scholar
  106. 106.
    Verma KK, Ovung EM, Sirka CS (2001) Extensive facial angiofibromas in tuberous sclerosis treated with carbon dioxide laserbrasion. Indian J Dermatol, Venereol Leprol 67:326–328Google Scholar
  107. 107.
    Quek SC, Yip W, Quek ST, Chang SK, Wong ML, Low PS (1998) Cardiac manifestations in tuberous sclerosis: a 10-year review. J Paediatr Child Health 34:283–287PubMedGoogle Scholar
  108. 108.
    Mariano A, Pita A, Leon R, Rossi R, Gouveia R, Teixeira A, Ferreira R, Anjos R, Menezes I, Martins FM (2009) Primary cardiac tumors in children: a 16-year experience. Revista portuguesa de cardiologia: orgao oficial da Sociedade Portuguesa de Cardiologia = Port J Cardiol Off J Port Soc Cardiol 28:279–288Google Scholar
  109. 109.
    Roach ES, Gomez MR, Northrup H (1998) Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 13:624–628PubMedGoogle Scholar
  110. 110.
    Kocabas A, Ekici F, Cetin II, Emir S, Demir HA, Ari ME, Degerliyurt A, Guven A (2013) Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome. Pediatr Hematol Oncol 30:71–79PubMedGoogle Scholar
  111. 111.
    Benyounes N, Fohlen M, Devys JM, Delalande O, Moures JM, Cohen A (2012) Cardiac rhabdomyomas in tuberous sclerosis patients: a case report and review of the literature. Arch Cardiovasc Dis 105:442–445PubMedGoogle Scholar
  112. 112.
    Riquet A, Cuisset JM, Cuvellier JC, Joriot S, Petit F, Vallee L (2010) Characteristics of tuberous sclerosis in children. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 17:1338–1345Google Scholar
  113. 113.
    Wataya-Kaneda M, Tanaka M, Hamasaki T, Katayama I (2013) Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients. PloS One 8:e63910PubMedCentralPubMedGoogle Scholar
  114. 114.
    Gil AT, Brett A, Cordinha C, Gomes C (2013) Bilateral renal cell carcinoma in a paediatric patient with tuberous sclerosis complex. BMJ Case Rep 2013Google Scholar
  115. 115.
    Rosado C, Garcia-Cosmes P, Fraile P, Vazquez-Sanchez F (2013) Tuberous sclerosis associated with polycystic kidney disease: effects of rapamycin after renal transplantation. Case Rep Transplant 2013:397087PubMedCentralPubMedGoogle Scholar
  116. 116.
    Lu CY, Min PQ, Wu B (2012) CT evaluation of spontaneously ruptured renal angiomyolipomas with massive hemorrhage spreading into multi-retroperitoneal fascia and fascial spaces. Acta Radiol Short Rep 1Google Scholar
  117. 117.
    Azmy AF, Stephenson J, Ziervogel M (1989) Angiomyolipoma causing life-threatening hematuria in a child with tuberous sclerosis. J Pediatr Surg 24:1308–1309PubMedGoogle Scholar
  118. 118.
    Stillwell TJ, Gomez MR, Kelalis PP (1987) Renal lesions in tuberous sclerosis. J Urol 138:477–481PubMedGoogle Scholar
  119. 119.
    Cabrera Lopez C, Marti T, Catala V, Torres F, Mateu S, Ballarin Castan J, Torra Balcells R (2011) Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 31:292–298Google Scholar
  120. 120.
    Henske EP, McCormack FX (2012) Lymphangioleiomyomatosis - a wolf in sheep’s clothing. J Clin Invest 122:3807–3816PubMedCentralPubMedGoogle Scholar
  121. 121.
    Seaman DM, Meyer CA, Gilman MD, McCormack FX (2011) Diffuse cystic lung disease at high-resolution CT. AJR Am J Roentgenol 196:1305–1311PubMedGoogle Scholar
  122. 122.
    De Pauw RA, Boelaert JR, Haenebalcke CW, Matthys EG, Schurgers MS, De Vriese AS (2003) Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis. Am J Kidney Dis Off J Natl Kidney Found 41:877–883Google Scholar
  123. 123.
    Benden C, Rea F, Behr J, Corris PA, Reynaud-Gaubert M, Stern M, Speich R, Boehler A (2009) Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 28:1–7Google Scholar
  124. 124.
    Taveira-Dasilva AM, Steagall WK, Moss J (2009) Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going. F1000 Med Rep 1Google Scholar
  125. 125.
    Curatolo P, Moavero R (2012) mTOR inhibitors in tuberous sclerosis complex. Curr Neuropharmacol 10:404–415PubMedGoogle Scholar
  126. 126.
    Johnson SR, Whale CI, Hubbard RB, Lewis SA, Tattersfield AE (2004) Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax 59:800–803PubMedGoogle Scholar
  127. 127.
    Curatolo P, Verdecchia M, Bombardieri R (2002) Tuberous sclerosis complex: a review of neurological aspects. Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc 6:15–23Google Scholar
  128. 128.
    Mettin RR, Merkenschlager A, Bernhard MK, Elix H, Hirsch W, Kiess W, Syrbe S (2013) Wide spectrum of clinical manifestations in children with tuberous sclerosis complex—follow-up of 20 children. Brain Dev (2013)Google Scholar
  129. 129.
    Pascual-Castroviejo I, Hernandez-Moneo JL, Pascual-Pascual SI, Viano J, Gutierrez-Molina M, Velazquez-Fragua R, Quinones Tapia D, Morales Bastos C (2012) Significance of tuber size for complications of tuberous sclerosis complex. Neurologia (in press)Google Scholar
  130. 130.
    Krueger DA (2013) Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis Complex. Curr Treat Options Neurol 15:618–633PubMedGoogle Scholar
  131. 131.
    Goh S, Butler W, Thiele EA (2004) Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 63:1457–1461PubMedGoogle Scholar
  132. 132.
    Amin S, Carter M, Edwards RJ, Pople I, Aquilina K, Merrifield J, Osborne JP, O’Callaghan FJ (2013) The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex. Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc 17:36–44Google Scholar
  133. 133.
    Sun P, Krueger D, Liu J, Guo A, Rogerio J, Kohrman M (2012) Surgical resection of subependymal giant cell astrocytomas (SEGAs) and changes in SEGA-related conditions: a US national claims database study. Curr Med Res Opin 28:651–656PubMedGoogle Scholar
  134. 134.
    Jozwiak S, Nabbout R, Curatolo P (2013) Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc 17:348–352Google Scholar
  135. 135.
    Beaumont TL, Limbrick DD, Smyth MD (2012) Advances in the management of subependymal giant cell astrocytoma. Child’s Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 28:963–968Google Scholar
  136. 136.
    Anonymous (2010) Novartis’ Afinitor cleared by FDA for treating SEGA tumors in tuberous sclerosis. Accessed 2010
  137. 137.
    Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, Dinopoulos A, Thomas G, Crone KR (2006) Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 59:490–498PubMedGoogle Scholar
  138. 138.
    Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE, Lamiell JM, Haines J, Yuen JW, Collins D, Majoor-Krakauer D et al (1988) Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332:268–269PubMedGoogle Scholar
  139. 139.
    Glasker S (2005) Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features. Fam Cancer 4:37–42PubMedGoogle Scholar
  140. 140.
    Hassard AD, Boudreau SF, Cron CC (1984) Adenoma of the endolymphatic sac. J Otolaryngol 13:213–216PubMedGoogle Scholar
  141. 141.
    Ong KR, Woodward ER, Killick P, Lim C, Macdonald F, Maher ER (2007) Genotype-phenotype correlations in von Hippel–Lindau disease. Hum Mutat 28:143–149PubMedGoogle Scholar
  142. 142.
    Butman JA, Linehan WM, Lonser RR (2008) Neurologic manifestations of von Hippel–Lindau disease. JAMA 300:1334–1342PubMedCentralPubMedGoogle Scholar
  143. 143.
    Richard S, Campello C, Taillandier L, Parker F, Resche F (1998) Haemangioblastoma of the central nervous system in von Hippel–Lindau disease. French VHL Study Group. J Intern Med 243:547–553PubMedGoogle Scholar
  144. 144.
    Wanebo JE, Lonser RR, Glenn GM, Oldfield EH (2003) The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 98:82–94PubMedGoogle Scholar
  145. 145.
    Schimke RN, Collins DL, Stolle CA (2009) Von Hippel–Lindau syndrome. University of Washington, SeattleGoogle Scholar
  146. 146.
    Tago M, Terahara A, Shin M, Maruyama K, Kurita H, Nakagawa K, Ohtomo K (2005) Gamma knife surgery for hemangioblastomas. J Neurosurg 102(Suppl):171–174PubMedGoogle Scholar
  147. 147.
    Wang EM, Pan L, Wang BJ, Zhang N, Zhou LF, Dong YF, Dai JZ, Cai PW, Chen H (2005) The long-term results of gamma knife radiosurgery for hemangioblastomas of the brain. J Neurosurg 102(Suppl):225–229PubMedGoogle Scholar
  148. 148.
    Niemela M, Lemeta S, Summanen P, Bohling T, Sainio M, Kere J, Poussa K, Sankila R, Haapasalo H, Kaariainen H, Pukkala E, Jaaskelainen J (1999) Long-term prognosis of haemangioblastoma of the CNS: impact of von Hippel–Lindau disease. Acta Neurochir (Wien) 141:1147–1156Google Scholar
  149. 149.
    Hes FJ, van der Luijt RB, Lips CJ (2001) Clinical management of von Hippel–Lindau (VHL) disease. Neth J Med 59:225–234PubMedGoogle Scholar
  150. 150.
    Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernandez-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425:851–856PubMedCentralPubMedGoogle Scholar
  151. 151.
    Balasundram S, Kovilpillai FJ, Hopper C (2010) Nevoid basal cell carcinoma syndrome presenting with neck pits and cafe au lait patches. J Clin Pediatr Dent 35:95–100PubMedGoogle Scholar
  152. 152.
    Shanley S, Ratcliffe J, Hockey A, Haan E, Oley C, Ravine D, Martin N, Wicking C, Chenevix-Trench G (1994) Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Am J Med Genet 50:282–290PubMedGoogle Scholar
  153. 153.
    Evans DG, Farndon PA, Burnell LD, Gattamaneni HR, Birch JM (1991) The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 64:959–961PubMedCentralPubMedGoogle Scholar
  154. 154.
    Amlashi SF, Riffaud L, Brassier G, Morandi X (2003) Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature. Cancer 98:618–624PubMedGoogle Scholar
  155. 155.
    Stavrou T, Bromley CM, Nicholson HS, Byrne J, Packer RJ, Goldstein AM, Reaman GH (2001) Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 23:431–436PubMedGoogle Scholar
  156. 156.
    Taipale J, Chen JK, Cooper MK, Wang B, Mann RK, Milenkovic L, Scott MP, Beachy PA (2000) Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine. Nature 406:1005–1009PubMedGoogle Scholar
  157. 157.
    Kleihues P, Schauble B, zur Hausen A, Esteve J, Ohgaki H (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 150:1–13PubMedGoogle Scholar
  158. 158.
    Li FP, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358–5362PubMedGoogle Scholar
  159. 159.
    Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, Eden OB, Varley JM (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20:4621–4628PubMedGoogle Scholar
  160. 160.
    Evans DG, Wu CL, Birch JM (2008) BRCA2: a cause of Li-Fraumeni-like syndrome. J Med Genet 45:62–63PubMedGoogle Scholar
  161. 161.
    Taylor MD, Mainprize TG, Rutka JT (2000) Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review. Neurosurgery 47:888–901PubMedGoogle Scholar
  162. 162.
    Foulkes WD (1995) A tale of four syndromes: familial adenomatous polyposis, Gardner syndrome, attenuated APC and Turcot syndrome. QJM 88:853–863PubMedGoogle Scholar
  163. 163.
    Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z, Tetu B et al (1995) The molecular basis of Turcot’s syndrome. N Engl J Med 332:839–847PubMedGoogle Scholar
  164. 164.
    Jamjoom ZA, Sadiq S, Mofti AB, al-Mofleh I, Ajarim D (1989) Turcot syndrome: report of a case and review of the literature. Int Surg 74:45–50PubMedGoogle Scholar
  165. 165.
    McLaughlin MR, Gollin SM, Lese CM, Albright AL (1998) Medulloblastoma and glioblastoma multiforme in a patient with Turcot syndrome: a case report. Surg Neurol 49:295–301PubMedGoogle Scholar
  166. 166.
    Schroder S, Moehrs D, von Weltzien J, Winkler R, Otto HF (1983) The Turcot syndrome. Report of an additional case and review of the literature. Dis Colon Rectum 26:533–538PubMedGoogle Scholar
  167. 167.
    Stevens CA (1993) Rubinstein–Taybi syndrome. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K (eds) Gene reviews. University of Washington, Seattle, WAGoogle Scholar
  168. 168.
    Burton BJ, Kumar VG, Bradford R (1997) Granular cell tumour of the spinal cord in a patient with Rubenstein-Taybi syndrome. Br J Neurosurg 11:257–259PubMedGoogle Scholar
  169. 169.
    Berdasco M, Esteller M (2013) Genetic syndromes caused by mutations in epigenetic genes. Hum Genet 132:359–383PubMedGoogle Scholar
  170. 170.
    Baumgart R, Burklein D, Hinterwimmer S, Thaller P, Mutschler W (2005) The management of leg-length discrepancy in Ollier’s disease with a fully implantable lengthening nail. J Bone Joint Surg Br 87:1000–1004PubMedGoogle Scholar
  171. 171.
    Shapiro F (1982) Ollier’s disease. An assessment of angular deformity, shortening, and pathological fracture in twenty-one patients. J Bone Joint Surg Am 64:95–103PubMedGoogle Scholar
  172. 172.
    Ranger A, Szymczak A (2009) Do intracranial neoplasms differ in Ollier disease and maffucci syndrome? An in-depth analysis of the literature. Neurosurgery 65:1106–1113, discussion 1113-1105PubMedGoogle Scholar
  173. 173.
    Schwartz HS, Zimmerman NB, Simon MA, Wroble RR, Millar EA, Bonfiglio M (1987) The malignant potential of enchondromatosis. J Bone Joint Surg Am 69:269–274PubMedGoogle Scholar
  174. 174.
    Maffucci A (1881) Di un caso encondroma ed angioma multiplo. Contribuzione alla genesi embrionale dei tumouri. Movimento medico-chirurgico, Napoli 3:399–412Google Scholar
  175. 175.
    Kast A, von Recklinghausen FD (1889) Ein Fall von Enchondrom mit ungewöhnlicher Multiplikation. Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medicin 118:1–11Google Scholar
  176. 176.
    Ollier L (1899) Dyschondroplasia. Bull Soc Lyon Med 93:23–24Google Scholar
  177. 177.
    Silve C, Juppner H (2006) Ollier disease. Orphanet J Rare Dis 1:37PubMedCentralPubMedGoogle Scholar
  178. 178.
    Balcer LJ, Galetta SL, Cornblath WT, Liu GT (1999) Neuro-ophthalmologic manifestations of Maffucci’s syndrome and Ollier’s disease. J Neuroophthalmol 19:62–66PubMedGoogle Scholar
  179. 179.
    Mellon CD, Carter JE, Owen DB (1988) Ollier’s disease and Maffucci’s syndrome: distinct entities or a continuum. Case report: enchondromatosis complicated by an intracranial glioma. J Neurol 235:376–378PubMedGoogle Scholar
  180. 180.
    Ahmed SK, Lee WC, Irving RM, Walsh AR (1999) Is Ollier’s disease an understaging of Maffucci’s syndrome? J Laryngol Otol 113:861–864PubMedGoogle Scholar
  181. 181.
    Bertucci V, Krafchik BR (1995) What syndrome is this? Ollier disease + vascular lesions: Maffucci syndrome. Pediatr Dermatol 12:55–58PubMedGoogle Scholar
  182. 182.
    Boinet E (1904) Enchondrose rachitiforme. Arch Gen de Med 194:2689–2717Google Scholar
  183. 183.
    Ranger A, Szymczak A, Hammond RR, Zelcer S (2009) Pediatric thalamic glioblastoma associated with Ollier disease (multiple enchondromatosis): a rare case of concurrence. J Neurosurg Pediatr 4:363–367PubMedGoogle Scholar
  184. 184.
    Ranger A, Szymczak A (2009) The association between intracranial tumours and multiple dyschondroplasia (Ollier’s disease or Maffucci’s syndrome): do children and adults differ? J Neurooncol 95:165–173PubMedGoogle Scholar
  185. 185.
    Altay M, Bayrakci K, Yildiz Y, Erekul S, Saglik Y (2007) Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients. J Orthop Sci 12:415–423PubMedGoogle Scholar
  186. 186.
    Ozisik YY, Meloni AM, Spanier SS, Bush CH, Kingsley KL, Sandberg AA (1998) Deletion 1p in a low-grade chondrosarcoma in a patient with Ollier disease. Cancer Genet Cytogenet 105:128–133PubMedGoogle Scholar
  187. 187.
    Bovee JV, van Roggen JF, Cleton-Jansen AM, Taminiau AH, van der Woude HJ, Hogendoorn PC (2000) Malignant progression in multiple enchondromatosis (Ollier’s disease): an autopsy-based molecular genetic study. Hum Pathol 31:1299–1303PubMedGoogle Scholar
  188. 188.
    Chang S, Prados MD (1994) Identical twins with Ollier’s disease and intracranial gliomas: case report. Neurosurgery 34:903–906, discussion 906PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Adrianna M. Ranger
    • 1
  • Yatri K. Patel
    • 1
  • Navjot Chaudhary
    • 2
  • Ram V. Anantha
    • 3
  1. 1.Department of Clinical Neurological SciencesWestern UniversityLondonCanada
  2. 2.Department of NeurosurgeryStanford School of MedicineStanfordUSA
  3. 3.Department of Surgery, Schulich School of Medicine and DentistryWestern UniversityLondonCanada

Personalised recommendations